July 29, 2020

Session one will provide an overview of the global initiatives in cervical cancer control, and opportunities to integrate these efforts in global maternal and child health (MCH), HIV, and other global health priorities.

About the series:

In 2018, according to the World Health Organization (WHO), approximately 570,000 women worldwide were diagnosed with cervical cancer. A shocking 311,000 women died of the disease. More than 80% of them were from low- and middle-income countries. While high-level institutions including the WHO are calling for action, it is crucial to understand the research, scientific advances, policy implementation considerations, and strategic coordination that are needed to reduce cervical cancer at the local and global level. A whole of society approach is required to reduce this disease, a preventable and treatable malignancy. This three-part webinar series brings together experts from the fields of research, clinical care, and policy, to debate and discuss what it will take to effectively reduce the global cervical cancer burden.


Marleen Temmerman, MD, PhD, MPH
Professor and Chair, Department of Obstetrics and Gynaecology and Director Women’s Health, Faculty of Heath Sciences, Aga Khan University, Kenya

Julie Torode, PhD
Director of Special Projects, Union for International Cancer Control, Switzerland

Isaac F. Adewole, MD
Professor, Obstetrics and Gynecology, University of Ibadan, Nigeria


Anne F. Rositch, MSPH, PhD
Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA